$DWTX

Dogwood Therapeutics Launches Phase 2b Clinical Trial for Non-Opioid Pain Treatment

$DWTX Dogwood Therapeutics, Inc. (Nasdaq: DWTX), a leading biopharmaceutical company, has announced the launch of its Phase 2b clinical trial,…